Citation: Rizwana, N.; Agarwal, V.;
Nune, M. Antioxidant for
Neurological Diseases and
Neurotrauma and Bioengineering
Approaches. Antioxidants 2022, 11, 72.
https://doi.org/10.3390/
antiox11010072
Academic Editors: Alessandra
Napolitano, Maria Cristina Albertini
and Seeram Ramakrishna
Received: 23 October 2021
Accepted: 20 December 2021
Published: 29 December 2021
Publisher’s Note: MDPI stays neutral
with regard to jurisdictional claims in
published maps and institutional affil-
iations.
Copyright: © 2021 by the authors.
Licensee MDPI, Basel, Switzerland.
This article is an open access article
distributed under the terms and
conditions of the Creative Commons
Attribution (CC BY) license (https://
creativecommons.org/licenses/by/
4.0/).
antioxidants
Review
Antioxidant for Neurological Diseases and Neurotrauma and
Bioengineering Approaches
Nasera Rizwana
1
, Vipul Agarwal
2,
* and Manasa Nune
1,
*
1
Manipal Institute of Regenerative Medicine (MIRM), Bengaluru, Manipal Academy of Higher
Education (MAHE), Manipal 576104, India; nasera.rizwana@learner.manipal.edu
2
Cluster for Advanced Macromolecular Design (CAMD), School of Chemical Engineering, University of New
South Wales, Sydney, NSW 2052, Australia
* Correspondence: agarwalvipul84@gmail.com (V.A.); manasa.nune@manipal.edu (M.N.)
Abstract: Antioxidants are a class of molecules with an innate affinity to neutralize reactive oxygen
species (ROS), which are known to cause oxidative stress. Oxidative stress has been associated with
a wide range of diseases mediated by physiological damage to the cells. ROS play both beneficial
and detrimental roles in human physiology depending on their overall concentration. ROS are
an inevitable byproduct of the normal functioning of cells, which are produced as a result of the
mitochondrial respiration process. Since the establishment of the detrimental effect of oxidative stress
in neurological disorders and neurotrauma, there has been growing interest in exploring antioxidants
to rescue remaining or surviving cells and reverse the neurological damage. In this review, we present
the survey of different antioxidants studied in neurological applications including neurotrauma. We
also delve into bioengineering approaches developed to deliver antioxidants to improve their cellular
uptake in neurological applications.
Keywords: antioxidants; oxidative stress; neurotrauma; neuroregeneration; bioengineering
approaches
1. Introduction
Oxidative stress induced by reactive oxygen species (ROS) is inevitably produced from
normal cellular metabolism through mitochondrial respiration and a family of membrane-
bound NADPH oxidases (NOXs). ROS are broadly divided into free radicals (molecules
with unpaired electrons) and non-radical species. Physiologically, three main ROS types are
superoxide anion (O
2
−
), hydroxyl radical (·OH), and hydrogen peroxide (H
2
O
2
)[1]. ROS
play an important role in both physiological cell functioning at low to moderate concentra-
tions by oxidizing different collocated proteins to activate multiple biochemical pathways
associated with cell viability, proliferation, differentiation and metabolic adaptation [2].
However, at high concentrations, ROS are toxic and cause oxidation-induced damage to
the pivotal cell components including lipids, proteins and DNA leading to cell cycle arrest
and cell death [3–7]. There is growing evidence showcasing that the excess oxidative stress
cause different pathological diseases including cancer, atherosclerosis, neurological disor-
ders, cardiovascular stress (hypertension, ischemia, reperfusion), diabetes mellitus, chronic
inflammation, acute respiratory distress syndrome, idiopathic pulmonary fibrosis, chronic
obstructive pulmonary disease, and asthma [8–10]. For example, atherosclerosis is caused
by ROS-mediated oxidation of the lipids in low-density lipoprotein (LDL) called lipid
peroxidation [11]. In cancer, ROS can promote cancer by introducing conducive genetic
mutations by oxidizing specific intracellular chemical moieties and activating biochemical
pathways that promote growth and neoplastic transformation [12]. Cancer cells survive
high ROS concentrations by preserving the intrinsic concentrations of reduced glutathione
and thioredoxin, which allows cells to activate proximal signaling pathways necessary for
Antioxidants 2022, 11, 72. https://doi.org/10.3390/antiox11010072 https://www.mdpi.com/journal/antioxidants